Dipna Pharmachem Limited (BOM:543594)
India flag India · Delayed Price · Currency is INR
4.220
-0.170 (-3.87%)
At close: Nov 16, 2026

Dipna Pharmachem Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
1,3091,2911,2491,643999.27727.55
Revenue Growth
33.44%3.33%-23.99%64.46%37.35%134.70%
Gross Profit
189.02215.57111.716444.3341.42
Operating Income
16.2149.8337.2734.2723.4121.7
Net Income
24.5626.329.7410.859.1211.67
Earnings Per Share
0.911.000.410.900.7669.46
EPS Growth
56.87%143.90%-54.44%18.42%-98.91%4721.77%

Cash & Debt

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
11.9211.9211.08148.9459.42.09
Total Debt
132.11132.11172.23194.45159.08101.89
Net Cash (Debt)
-120.19-120.19-161.15-45.51-99.67-99.8
Net Cash Growth
------
Net Cash Per Share
-4.46-4.57-6.78-3.77-8.31-594.06

Cash Flow & CapEx

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
--183.22-91.95-54.17-209.7628.05
Capital Expenditures
--0.41-0.2-0.15-0.1-0.07
Free Cash Flow
--183.63-92.15-54.31-209.8627.99
Free Cash Flow Growth
------

Margins

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
14.44%16.70%8.94%3.89%4.44%5.69%
Operating Margin
1.24%3.86%2.98%2.09%2.34%2.98%
Pretax Margin
2.67%2.75%1.14%0.86%1.38%2.16%
Profit Margin
1.88%2.04%0.78%0.66%0.91%1.60%
FCF Margin
--14.23%-7.38%-3.31%-21.00%3.85%

Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingNov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
4.828.0135.3020.8716.47-
PS Ratio
0.090.160.280.140.15-